BPC-157Ulcerative colitis
Committee favored
No final legal changeNot FDA approved
FDA actionTiming not announced
Find the current status. See the source.
Search 17 widely discussed peptides and see—in plain language—what FDA has done, what it has not done, and what comes next.
KPVWound healing and inflammatory conditions
Committee favored
No final legal changeNot FDA approved
FDA actionTiming not announced
TB-500Wound healing
Committee favored
No final legal changeNot FDA approved
FDA actionTiming not announced
MOTS-cObesity and osteoporosis
Committee favored
No final legal changeNot FDA approved
FDA actionTiming not announced
EpitalonInsomnia
Committee favored
No final legal changeNot FDA approved
FDA actionTiming not announced
SemaxCerebral ischemia, migraine, and trigeminal neuralgia
Committee favored
No final legal changeNot FDA approved
FDA actionTiming not announced
Emideltide / DSIPOpioid withdrawal, chronic insomnia, and narcolepsy
Committee did not favor
No final legal changeNot FDA approved
FDA responseTiming not announced
LL-37Uses to be specified in forthcoming meeting materials
Awaiting review
No final legal changeNot FDA approved
FDA advisory meetingBefore the end of Feb 2027
GHK-CuUses to be specified in forthcoming meeting materials
Awaiting review
No final legal changeNot FDA approved
FDA advisory meetingBefore the end of Feb 2027
Dihexa acetateUses to be specified in forthcoming meeting materials
Awaiting review
No final legal changeNot FDA approved
FDA advisory meetingBefore the end of Feb 2027
Melanotan IIUses to be specified in forthcoming meeting materials
Awaiting review
No final legal changeNot FDA approved
FDA advisory meetingBefore the end of Feb 2027
PEG-MGFUses to be specified in forthcoming meeting materials
Awaiting review
No final legal changeNot FDA approved
FDA advisory meetingBefore the end of Feb 2027
AOD-9604Obesity
Committee did not favor
No final legal changeNot FDA approved
FDA responseTiming not announced
CJC-1295Growth hormone deficiency
Committee did not favor
No final legal changeNot FDA approved
FDA responseTiming not announced
Ipamorelin acetatePostoperative gastrointestinal recovery (study context)
FDA safety concern
FDA safety concernNot FDA approved
Further FDA evaluationTiming not announced
Selank acetateGeneralized anxiety disorder and neurasthenia (study context)
FDA safety concern
FDA safety concernNot FDA approved
Further FDA evaluationTiming not announced
Thymosin alpha-1Hepatitis B, hepatitis C, HIV, COVID-19, vaccine response, cancers, sepsis, transplant infections, COPD, and ME/CFS
Committee did not favor
No final legal changeNot FDA approved
FDA responseTiming not announced
ALERT WAITLIST
Tell us which updates would be useful.
Your saved compounds are preselected below. Email alerts are not active yet; this waitlist helps us decide whether to build them.